Superworth

Allarity Therapeutics shares outstanding ALLR

Diluted shares outstanding, averaged over each quarter, from 2020.

Latest quarter, to Jun 30, 2024
499.3K
On a year earlier
+80341.9%
more shares

Allarity Therapeutics had 499.3K diluted shares outstanding on average in Q2 FY24, the quarter to Jun 30, 2024.

That is 80341.9% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY20238.7K+69084%
FY202213+30%
FY202110+101%
FY20205n/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q2 FY24499.3K+80342%
Q1 FY245.8K+33094%
Q4 FY238.7K+69084%
Q3 FY234.1K+34497%
Q2 FY23621+210%
Q1 FY2318+78%
Q4 FY2213+30%
Q3 FY2212+29%
Q2 FY22200+3255%
Q1 FY2210+83%
Q4 FY2110+101%
Q3 FY219+108%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Allarity Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.